Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Milestone Pharmaceuticals Inc. (MIST)
|
Add to portfolio |
|
|
|
| Price: |
$7.45
| | Metrics |
| OS: |
33.4
|
M
| |
|
|
| Market cap: |
$249
|
M
| |
|
|
|
Net cash:
|
$39.5
|
M
| |
$1.18
|
per share
|
|
EV:
|
$209
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 15.0 | -5.9 | -8.9 | -3.9 | 8.3 |
| Revenue growth | -352.7% | -33.2% | 126.8% | -147.4% | |
| Cost of goods sold | 7.0 | 0.0 | 0.0 | 0.0 | 8.3 |
| Gross profit | 8.0 | -5.9 | -8.9 | -3.9 | 0.0 |
| Gross margin | 53.3% | 100.0% | 100.0% | 100.0% | 0.0% |
| Research and development | 38.7 | 34.5 | 42.0 | 16.8 | |
| General and administrative | 12.4 | 10.3 | 7.0 | 3.1 | 1.5 |
| EBIT | -43.1 | -50.7 | -57.9 | -23.8 | -8.3 |
| EBIT margin | -287.2% | 854.1% | 650.9% | 607.5% | -100.0% |
| Pre-tax income | -42.9 | -50.0 | -55.3 | -23.1 | 0.0 |
| Income taxes | 0.0 | 0.0 | -0.1 | 0.1 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.1% | | |
| Net income | -42.9 | -50.0 | -55.2 | -23.2 | 0.0 |
| Net margin | -285.7% | 841.6% | 621.1% | 591.3% | 0.0% |
| |
| Diluted EPS | ($1.02) | ($1.70) | ($3.50) | ($72.63) | |
| Shares outstanding (diluted) | 42.0 | 29.4 | 15.8 | 0.3 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|